Genetic Technologies Ltd (NASDAQ:GENE)

3.06
Delayed Data
As of 1:53pm ET
 -0.06 / -1.92%
Today’s Change
1.04
Today|||52-Week Range
11.00
+58.92%
Year-to-Date
Institutional investors purchased a net $843.9 thousand shares of GENE during the quarter ended December 2014. This may signal that the smart money is gaining interest in this company as the 8.11% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders--
Individual stakeholders--
Other institutional--

Largest Quarterly Institutional
Transactions

Chart unavailable

Latest Institutional Activity

Top 10 Owners of Genetic Technologies Ltd

StockholderStakeShares
owned
Total value ($)Shares
bought / sold
Total
change
Renaissance Technologies LLC5.70%650,7802,642,167+591,980+1,006.77%
Wolverine Asset Management LLC1.16%133,000539,980+133,000--
Millennium Management LLC0.48%54,438221,018+54,438--
Citadel Advisors LLC0.36%40,738165,396+40,738--
BMO Capital Markets (Canada)0.13%15,00060,900+15,000--
Jane Street Capital LLC0.12%13,47754,717+13,477--
KCG Americas LLC0.10%11,31145,923+7,372+187.15%
Alpine Securities USVI LLC0.02%2,2209,01300.00%
Morgan Stanley & Co. LLC0.02%1,8227,397+1,818+45,450.00%
UBS Securities LLC0.02%1,8177,377+1,817--

Top 10 Mutual Funds Holding Genetic Technologies Ltd

Mutual fundStakeShares
owned
Total value ($)Shares
bought / sold
Total
change

To view my watchlist

Not a member yet?

Sign up now for a free account